Difference between revisions of "Template:Dopamine receptor modulators"
Jump to navigation
Jump to search
imported>Medgirl131 |
imported>Whywhenwhohow (remove extra plus) |
||
| Line 89: | Line 89: | ||
* [[Norclozapine]]<!--Relatively strong--> | * [[Norclozapine]]<!--Relatively strong--> | ||
* [[Norquetiapine]] | * [[Norquetiapine]] | ||
| − | * [[Olanzapine]]<!--Relatively weak--> ( | + | * [[Olanzapine]]<!--Relatively weak--> ([[olanzapine/fluoxetine|+fluoxetine]]) |
* [[Paliperidone]]<!--Relatively weak--> | * [[Paliperidone]]<!--Relatively weak--> | ||
* [[Quetiapine]] | * [[Quetiapine]] | ||
Latest revision as of 07:14, 1 October 2020
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Dopamine receptor modulators|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Dopamine receptor modulators|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Dopamine receptor modulators|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.